How to Respond to a Medicare ADR Letter for Opioid Treatment Program (OTP): OTP Bundled Payment Billing Compliance

Learn CMS’s OTP weekly bundled payment structure and billing rules and how to build a defensible ADR response for bundled payment claims.

KNOWLEDGE CENTER

7/29/20267 min read

Medicare pays opioid treatment programs through a weekly bundled payment structure built around specific HCPCS G-codes tied to each authorized medication, with each code covering a seven-day episode of care that bundles medication dispensing and administration, substance use counseling, individual and group therapy, and toxicology testing if performed. Because this bundled structure carries its own specific rules regarding episode timing, billing thresholds, and the relationship between drug and non-drug components, an ADR challenging OTP bundled payment billing requires a response that demonstrates fluency with this distinctive payment methodology rather than a general behavioral health billing framework.

This article explains the OTP weekly bundled payment structure and its component codes, the specific billing rules governing episode timing and thresholds, why this billing category draws sustained ADR attention, and how OTPs should structure an effective response when bundled payment billing is challenged. It closes with how HealthBridge US supports Opioid Treatment Programs strengthening bundled payment billing compliance.

The Weekly Bundled Payment Code Structure

Medicare pays OTPs through medication-specific weekly bundle codes, including a code for methadone, a code for oral buprenorphine, a code for injectable buprenorphine, and a code for naltrexone, each covering a seven-day episode of care that bundles medication dispensing and administration alongside substance use disorder counseling, individual and group therapy, and toxicology testing where performed. Where an OTP does not provide a drug to the patient during a given week’s episode, a separate code describing the weekly bundle without the drug component applies instead, provided at least one non-drug service, such as counseling, was furnished during that week.

The Seven-Day Episode and Billing Threshold Rules

For the codes describing a weekly bundle, one week is defined as seven consecutive days, and the threshold for billing these codes is the delivery of at least one service falling within the applicable weekly bundle, whether from the drug component or the non-drug component. OTPs should not bill for the same patient more than once for the same seven-day period under the standard weekly bundle structure, and documentation should clearly reflect the specific dates comprising each billed weekly episode to support this one-bundle-per-week billing rule.

Add-On Codes Supporting Additional Services

Beyond the base weekly bundle, Medicare recognizes several specific add-on codes supporting services exceeding what the base bundle contemplates. An add-on code covers intake activities for new patients beginning opioid use disorder treatment, applicable only at the outset of treatment rather than for later reassessments. A separate add-on code covers periodic patient assessments furnished after the initial intake period. Another add-on code covers each additional 30 minutes of counseling furnished within a week of medication-assisted treatment when this counseling meaningfully exceeds what the patient’s individualized treatment plan contemplates. Take-home medication supply add-on codes are specifically tied to their corresponding weekly bundle code, such that a take-home methadone supply code may only be billed alongside the methadone weekly bundle code, and similarly for oral buprenorphine.

Documentation Supporting Bundled Payment Claims

Effective documentation should clearly reflect which specific services were furnished during each billed weekly episode, supporting both the base bundle code selected and any add-on codes billed alongside it. Where the base bundle without the drug component is billed for a given week, documentation should specifically reflect the non-drug service furnished during that period, since this documentation is what establishes the claim satisfied the required billing threshold in the absence of medication dispensing that week.

Addressing Exceptions to the Standard Weekly Billing Cycle

CMS permits billing bundled payment codes more than once within a seven-day period in certain limited situations, such as when a patient is first starting treatment and the OTP needs to synchronize that patient with the program’s standard weekly billing cycle, or during holiday weeks when the OTP is closed for a portion of the week. These exceptions require a specific modifier on the claim along with documentation of the valid reason supporting this deviation from the standard weekly billing structure, and OTPs relying on this exception should ensure the underlying documentation clearly and specifically explains the circumstances justifying it.

Why Bundled Payment Billing Draws Sustained ADR Attention

Because the OTP bundled payment structure involves multiple distinct codes tied to specific medications, specific timing rules, and specific add-on relationships, reviewing contractors examine whether the specific weekly bundle code billed corresponds to the medication actually administered, whether the seven-day episode timing is correctly applied, whether add-on codes are billed only in connection with their specifically required base code, and whether any deviation from the standard weekly billing cycle is supported by the specific documented justification CMS requires. Given how specific and interconnected these billing rules are, this area presents considerable opportunity for both inadvertent billing errors and legitimate documentation-supported claims that nonetheless require careful, specific substantiation.

Building an Effective ADR Response

When an ADR challenges OTP bundled payment billing, the response should include the complete medication administration record supporting the specific weekly bundle code billed, documentation of the non-drug service furnished for any week billed under the no-drug bundle code, and, for any claim relying on the more-than-once-per-week exception, the specific documented justification supporting that deviation. Where a genuine discrepancy exists between the medication administered and the code billed, the program should address this directly and assess whether the same discrepancy pattern may affect other claims given how this kind of coding error can recur systematically if tied to a billing system configuration issue.

Common Bundled Payment Documentation Gaps

Several recurring gaps appear in OTP bundled payment reviews. Claims billed under a specific medication’s weekly bundle code without medication administration documentation clearly supporting that specific medication represent a frequently cited issue. Take-home supply add-on codes billed without a corresponding, currently valid weekly bundle code for the same medication represent another common gap. Claims relying on the more-than-once-weekly exception without the specific required modifier and supporting documentation of the valid justification round out a frequent finding in this area.

Verifying Take-Home Supply Billing Units Reflect the Authorized Quantity

Because take-home supply add-on codes are billed in units corresponding to additional days of medication, up to a maximum reflecting approximately a one-month supply when combined with the standard weekly bundle, programs should ensure the specific number of units billed accurately reflects the clinically authorized take-home quantity documented in the patient’s record. Billing a higher number of units than the documented authorization supports, even inadvertently through a billing system default setting, creates a specific, readily identifiable discrepancy between the clinical record and the submitted claim that a reviewing contractor would likely flag during a detailed bundled payment review.

Addressing the Relationship Between the Periodic Assessment Add-On and Ongoing Care

Because the periodic assessment add-on code applies specifically to assessments furnished after the initial intake period, programs should ensure billing staff correctly distinguish between the intake-specific add-on code, applicable only to new patients beginning treatment, and the periodic assessment add-on code, applicable to reassessments occurring later in the patient’s treatment course. Billing the intake-specific code for a reassessment that actually occurred well after a patient’s initial admission represents a specific coding error distinct from, though related to, the broader bundled payment billing accuracy concerns this article addresses.

Building a Reconciliation Process Between Clinical Records and Claims Data

Programs should build a systematic reconciliation process comparing the medication administration record and counseling documentation against the specific codes billed for each patient’s weekly episodes, ideally before claims submission rather than only during a subsequent audit response. This proactive reconciliation catches coding discrepancies, such as a mismatch between the documented medication and the billed weekly bundle code, while there is still an opportunity to correct the claim before submission, rather than discovering the discrepancy only after a reviewing contractor has already identified it during an external audit.

Training Billing Staff on the Specific Add-On Code Relationships

Because several OTP add-on codes are specifically tied to a particular base weekly bundle code, such as the buprenorphine-specific take-home supply code that may only be billed alongside the oral buprenorphine weekly bundle, billing staff should receive targeted training addressing these specific code relationships rather than treating all add-on codes as generically applicable across any base bundle code. Staff who understand these specific pairing requirements are better positioned to catch a mismatched code combination before claim submission, reducing the volume of billing errors that might otherwise only be identified during a subsequent external review.

Addressing Documentation Consistency Across Multiple Billing Cycles

Because OTP treatment often extends across many consecutive weekly billing cycles, programs should verify that documentation and billing remain consistent as a patient’s treatment continues over time, particularly through any medication transitions, dosing changes, or periods of missed or interrupted treatment that might affect which specific code applies to a given week. A chart and billing review spanning an extended treatment period should specifically verify that the sequence of billed weekly codes accurately reflects the patient’s actual treatment course throughout, rather than assuming consistency based only on a sample of individual weeks examined in isolation.

Addressing Telehealth Modifiers Within Bundled Payment Claims

Because certain OTP services, including intake activities, periodic assessments, and additional counseling, may be furnished through audio-video or audio-only telehealth technology, and because claims for dates of service on or after May 12, 2023 require specific modifiers reflecting which technology was used, programs should ensure billing staff correctly apply these modifiers based on the actual documented modality for each specific service. A mismatch between the documented telehealth modality and the modifier applied on the claim represents a specific, correctable billing accuracy issue that a pre-submission reconciliation process can catch before it becomes the subject of an external review.

Building a Recurring Internal Audit Addressing Bundled Payment Accuracy

Given how many distinct, interconnected rules govern OTP bundled payment billing, programs benefit from a recurring internal audit specifically sampling weekly episodes across different medications and billing scenarios, verifying code selection, add-on pairing, take-home unit accuracy, and telehealth modifier application. Programs that build this recurring review into their standing compliance calendar are better positioned to catch and correct billing errors before they accumulate across a larger volume of claims.

How HealthBridge US Supports Your Opioid Treatment Program

The OTP weekly bundled payment structure involves multiple interconnected codes, specific timing rules, and add-on relationships that each require precise documentation support. HealthBridge US supports Opioid Treatment Programs with bundled payment billing audits, medication-to-code reconciliation review, and ADR response support. If your program wants to strengthen bundled payment billing accuracy, verify add-on code compliance, or needs support responding to an active ADR, HealthBridge US is here to help — contact our team to discuss your program’s billing compliance needs.

References

• Centers for Medicare & Medicaid Services. “Opioid Treatment Program (OTP) Billing & Payment.” https://www.cms.gov/medicare/payment/opioid-treatment-program/billing-payment

• Centers for Medicare & Medicaid Services. “Opioid Treatment Programs (OTPs) Medicare Billing and Payment” (MLN Booklet). https://www.cms.gov/sites/default/files/2020-12/ICNMLN8296732_2020_12_OTP_Billing_and_Payment_Print_Friendly_508.pdf

• Electronic Code of Federal Regulations. 42 CFR § 410.67 (Opioid Use Disorder Treatment Services). https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-410/subpart-B/section-410.67

• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 39 (Opioid Treatment Programs). https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/clm104c39.pdf

• Centers for Medicare & Medicaid Services. “Additional Documentation Request.” https://www.cms.gov/data-research/monitoring-programs/medicare-fee-service-compliance-programs/medical-review-education/additional-documentation-request

• Centers for Medicare & Medicaid Services. Medicare Claims Processing Manual, Chapter 29 (Appeals). https://www.cms.gov/regulations-and-guidance/guidance/manuals/downloads/clm104c29.pdf

HealthBridge US is here to help. Our compliance specialists support Opioid Treatment Programs with bundled payment billing review and Medicare ADR response — contact us to protect your program’s reimbursement.

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.

The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.

HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.

© 2026 HealthBridge US, a California corporation. All rights reserved.

For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance

Legal

Resources

Based in Los Angeles, California, operating in all 50 states.